1. Home
  2. VERU vs PETS Comparison

VERU vs PETS Comparison

Compare VERU & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.74

Market Cap

45.0M

Sector

Health Care

ML Signal

HOLD

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

HOLD

Current Price

$1.85

Market Cap

41.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERU
PETS
Founded
1971
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
41.7M
IPO Year
1996
2003

Fundamental Metrics

Financial Performance
Metric
VERU
PETS
Price
$2.74
$1.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
244.5K
90.2K
Earning Date
05-12-2026
06-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,296,958.00
$273,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$1.57
52 Week High
$7.33
$4.10

Technical Indicators

Market Signals
Indicator
VERU
PETS
Relative Strength Index (RSI) 58.12 46.65
Support Level $2.12 $1.71
Resistance Level $2.87 $1.87
Average True Range (ATR) 0.15 0.06
MACD 0.02 -0.01
Stochastic Oscillator 75.89 39.71

Price Performance

Historical Comparison
VERU
PETS

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

Share on Social Networks: